Deans' stroke musings: Non-linear and spectral EEG dynamics as stage–specific biomarkers of neuropsychological recovery post-stroke

Changing stroke rehab and research worldwide now.Time is Brain! trillions and trillions of neurons that DIE each day because there are NO effective hyperacute therapies besides tPA(only 12% effective). I have 523 posts on hyperacute therapy, enough for researchers to spend decades proving them out. These are my personal ideas and blog on stroke rehabilitation and stroke research. Do not attempt any of these without checking with your medical provider. Unless you join me in agitating, when you need these therapies they won't be there.

What this blog is for:

My blog is not to help survivors recover, it is to have the 10 million yearly stroke survivors light fires underneath their doctors, stroke hospitals and stroke researchers to get stroke solved. 100% recovery. The stroke medical world is completely failing at that goal, they don't even have it as a goal. Shortly after getting out of the hospital and getting NO information on the process or protocols of stroke rehabilitation and recovery I started searching on the internet and found that no other survivor received useful information. This is an attempt to cover all stroke rehabilitation information that should be readily available to survivors so they can talk with informed knowledge to their medical staff. It lays out what needs to be done to get stroke survivors closer to 100% recovery. It's quite disgusting that this information is not available from every stroke association and doctors group.

Tuesday, September 1, 2026

Non-linear and spectral EEG dynamics as stage–specific biomarkers of neuropsychological recovery post-stroke

You are that blitheringly stupid that you think biomarkers get you recovered! You need EXACT protocols that get you recovered!

WOW!

Non-linear and spectral EEG dynamics as stage–specific biomarkers of neuropsychological recovery post-stroke

1. Institute of Higher Nervous Activity and Neurophysiology RAS, Moscow, Russia
2. Laboratory of Experimental Neurology and Neuroimaging, Federal Research and Clinical Center of Intensive Care Medicine and Rehabilitology, Moscow, Russia

Abstract

Introduction:

Resting-state electroencephalography (EEG) offers promising window into the neuroplastic changes underlying recovery after stroke. This longitudinal study aimed to characterize the stage-specific dynamics of non-linear (fractal dimension, FD) and linear (power spectral density, PSD) EEG metrics and to evaluate their associations with recovery of neuropsychological functions.

Methods:

We recruited 44 patients with left-hemisphere ischemic stroke at various recovery stages and 25 age-matched healthy controls. All participants underwent high-density EEG recording at two time points (~5–7 weeks apart). The EEG was analyzed for FD, PSD across standard frequency bands.

Results:

A rehabilitation-related increase in FD in the right hemisphere was observed in all patient groups except those in the early recovery stage, where a unique decrease in left-hemisphere FD occurred. This right-hemispheric FD increase correlated with improvements in motor control function. Spectral changes were also stage-specific: a decrease in frontal beta power (14–20 Hz) was linked to longer inter-session intervals, while a right posterior increase in slow-wave activity (2–6 Hz) correlated with gains in auditory-verbal memory. Conversely, a reduction in alpha power (7–9 Hz) was associated with improved visuospatial ability and motor functions, but only in early and intermediate recovery stages. Recovery after stroke is subserved by dynamic, phase-specific neurophysiological processes reflected in the FD and spectral composition of spontaneous brain activity. The right hemisphere appears to play a crucial compensatory role, with FD serving as a sensitive biomarker of motor planning recovery.

Conclusion:

These findings underscore the necessity of stage-specific neurorehabilitation framework, informed by objective EEG biomarkers, to individualize and enhance therapeutic efficacy.